Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Atsushi Kurusu"'
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 22, Iss 5, Pp 207-210 (2006)
The objective of the present study was to investigate whether InBody 2.0 might be useful in measuring the dry weight of chronic hemodialysis (HD) patients. Thirty-five HD patients (22 males and 13 females; mean age 62.6 ± 14.0 years; mean HD duratio
Externí odkaz:
https://doaj.org/article/0cd8d4e568d04246b14d00f8446135ab
Autor:
Atsushi Kurusu, Yukihiko Takeda, Isao Ohsawa, Yoshio Shimizu, Yusuke Suzuki, Yuko Makita, Satoshi Horikoshi, Yuichi Tanaka, Yasuhiko Tomino, Yutaka Kanamaru
Publikováno v:
Juntendo Medical Journal. 60:353-357
Autor:
Arisa Ishii, Aya Yamahatsu, Yoshio Shimizu, Yasuhiko Tomino, Atsushi Kurusu, Hiroaki Io, Satoshi Horikoshi, Chieko Hamada, Akiko Takahata, Tadahiro Kajiyama
Publikováno v:
Case Reports in Nephrology and Urology
In 2011, simultaneous, widespread outbreaks of food poisoning by contaminated enterohemorrhagic Escherichia coli in beef, which killed four and hospitalized more than 30 people, occurred in Japan. While the press was widely reporting this disaster, t
Autor:
Yuichi Tanaka, Yukihiko Takeda, Chieko Hamada, Hitoshi Suzuki, Noriyoshi Kobayashi, Yasuhiko Tomino, Satoshi Horikoshi, Katsuhiko Asanuma, Toshinao Tsuge, Yoshio Shimizu, Atsushi Kurusu, Yusuke Suzuki, Hiroaki Io, Isao Ohsawa, Junichiro Nakata, Katsuhiko Takara
Publikováno v:
Journal of Nephrology. 24:756-763
BACKGROUND The long-term antiproteinuric effects of benidipine, a calcium channel blocker (CCB), have not been evaluated in detail in hypertensive patients with chronic kidney disease (CKD). METHODS Benidipine (4 mg/day) was administered to previousl
Autor:
Atsushi Kurusu, Yusuke Suzuki, Junichiro Nakata, Takashi Yao, Makoto Fujime, Koichi Ito, Yasuhiko Tomino, Satoshi Horikoshi, Tatsuya Ogishima, Noriyoshi Kobayashi, Atsushi Arakawa, Isao Ohsawa, Yohei Sasaki
Publikováno v:
Juntendo Medical Journal. 57:644-649
Autor:
Atsushi Kurusu, Kazuhiko Funabiki, Yasuhiko Tomino, Yoshimi Sekiguchi, Hirotaka Nakamoto, Hiroaki Io, Tomohito Gouda, Takayuki Hasegawa, Michiko Satoh, Kunimi Maeda, Chieko Hamada, Kayo Kaneko, Satoshi Horikoshi
Publikováno v:
Juntendo Medical Journal. 55:289-293
Autor:
Atsushi Kurusu, Mitsumine Fukui, Yasuhiko Tomino, Ichiyu Shou, Machiko Okamoto, Kunimi Maeda, Chieko Hamada
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 22, Iss 5, Pp 207-210 (2006)
The objective of the present study was to investigate whether InBody 2.0 might be useful in measuring the dry weight of chronic hemodialysis (HD) patients. Thirty-five HD patients (22 males and 13 females; mean age 62.6 +/- 14.0 years; mean HD durati
Autor:
Atsushi Kurusu, Tomohide Horiuchi, Kyouichi Tashiro, Seiki Aruga, Mitsumine Fukui, Ichiyu Shou, Yasuhiko Tomino, Satoshi Horikoshi
Publikováno v:
Journal of Clinical Laboratory Analysis. 19:80-83
In 2002, the Joint Committee of the Special Study Group on Progressive Glomerular Diseases, Ministry of Health, Labor and Welfare of Japan newly revised the clinical guidelines for IgA nephropathy (Sakai et al.: Jpn J Nephrol 37:417–421, 1995; Tomi
Autor:
Atsushi Kurusu, Ichiyu Shou, Yasuhiko Tomino, Kazuhiko Funabiki, Sanki Kodera, Toshimasa Hishiki, Isao Shirato, Kyoichi Tashiro, Satoshi Horikoshi
Publikováno v:
Nephrology. 6:93-98
SUMMARY: Programmed cell death is a selective process of physiological cell deletion and is known as apoptosis. The purpose of the present study was to determine the relationship between the existence of apoptotic cells in glomeruli and the clinical
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 27:767-770
SUMMARY 1. The effects of 11 week treatments with the new hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor fluvastatin on renal intrinsic anti-oxidant enzyme (AOE) activities and renal function were evaluated in streptozotocin (STZ)-